Read Software Trends

Wednesday, January 7, 2015

Infor M3 Helps Dexcel Pharma Improve Visibility and Agility

Infor, a provider of business application software serving more than 73,000 customers in 200 countries around the globe, recently announced that Israeli pharmaceutical manufacturer Dexcel Pharma, has globally implemented Infor M3.

Dexcel Pharma is a private, international pharmaceutical company, with over 1,000 employees. It is the second largest Israeli pharmaceutical manufacturer, supplying 25 percent of the branded and generic pharmaceuticals sold in Israel.

Infor's Enterprise Resource Planning (ERP) application will help improve decision making and visibility, enabling Dexcel Pharma to achieve enhanced uniformity across its companies in the UK, Germany and Israel.

Infor M3 will also help deliver consistency and facilitate transparency across the information generated by Dexcel's sales and distribution operations in Europe and the corporate headquarters in Israel, while supporting Dexcel's adherence to high standards of compliance required in the pharmaceutical industry. Automated warehouse and inventory module terminals have also been integrated, while the development of specific modules to synchronize all sites means that Dexcel is able to exercise greater agility through having consistent information. Infor's flexible deployment options also gave Dexcel Pharma a choice to run their businesses in the cloud, on-premises, or both.

To read more about the Infor M3 implementation, view additional case studies, and learn more about the industry-specific applications and suites Infor specializes in, visit the Infor Newsroom.

The Brown Smith Wallace 2014-15 Distribution and Manufacturing Software Guides are currently available for download. Please contact snelson@bswllc.com for more information about these latest editions.

 
2014 Manufacturing Software Guide: 
 
Additional materials: 
 
Follow Us on Twitter
 
 

No comments:

Add to Technorati Favorites